Peptides that bind to the erythropoietin receptor

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/505 (2006.01) A61K 38/18 (2006.01) A61P 7/06 (2006.01)

Patent

CA 2525497

The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided. The peptides can be in monomeric or dimeric forms and are eventually conjugated to PEG. The peptides have from 1 to 40 residues and comprise the sequence: LYACHX0GPITX1VCQPLR, wherein X0 is H or homoserine methylether; X1 is W or 1-nal or 2-nal.

L'invention porte sur des composés de peptides agonistes du récepteur de l'érythropoïétine (EPO-R), sur des méthodes thérapeutiques utilisant lesdits composés pour traiter les troubles associés à une production insuffisante ou défectueuse de globules rouges, et sur des préparations pharmaceutiques comprenant lesdits composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Peptides that bind to the erythropoietin receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides that bind to the erythropoietin receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides that bind to the erythropoietin receptor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1487800

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.